Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial

ARTICLE: A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial AUTHORS: John Z Metcalfe, Isabelle R… Read More »A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial

Real-World Experience with an Electronic Patient-Reported Outcome Measure in Care of Patients with Non-Dialysis-Dependent CKD

ARTICLE: Real-World Experience with an Electronic Patient-Reported Outcome Measure in Care of Patients with Non-Dialysis-Dependent CKD AUTHORS: Dipal M Patel, Dingfen Han, Mary Ann C… Read More »Real-World Experience with an Electronic Patient-Reported Outcome Measure in Care of Patients with Non-Dialysis-Dependent CKD